Sign in

CIK 0002012593

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Rapport Therapeutics, Inc.

Sign in to watch
Ticker
RAPP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880724208
Phone
+1 857-321-8020
Business address
99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
Former names
Rapport Therapeutics, Inc.
Open-market buys, last 90 days
$22,023,904
in 7 filings
Open-market sales, last 90 days
$4,470,180
in 7 filings, $4.5M under 10b5-1 plans

Net +$17,553,724. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-12-17 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −2,147 $28.84 $62K 33,831
2025-12-17 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −2,421 $30.04 $73K 31,410
2025-12-17 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −515 $31.04 $16K 30,895
2025-12-15 Bredt David Chief Scientific Officer Sale 10b5-1 −7,704 $29.95 $231K 393,438
2025-12-15 Bredt David Chief Scientific Officer Sale 10b5-1 −796 $30.68 $24K 392,642
2025-11-26 Gault Cheryl Chief Operating Officer Sale 10b5-1 −5,000 $30.10 $150K 171,928
2025-11-17 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −2,777 $24.92 $69K 576,802
2025-11-17 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −3,056 $25.43 $78K 573,746
2025-11-17 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −2,242 $24.91 $56K 38,819
2025-11-17 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −2,841 $25.44 $72K 35,978
2025-11-17 Bredt David Chief Scientific Officer Sale 10b5-1 −3,156 $24.84 $78K 406,486
2025-11-17 Bredt David Chief Scientific Officer Sale 10b5-1 −5,344 $25.39 $136K 401,142
2025-10-15 Bredt David Chief Scientific Officer Sale 10b5-1 −7,418 $25.73 $191K 410,724
2025-10-15 Bredt David Chief Scientific Officer Sale 10b5-1 −1,082 $26.16 $28K 409,642
2025-10-15 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −4,647 $25.72 $120K 580,765
2025-10-15 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −1,186 $26.14 $31K 579,579
2025-10-15 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −4,328 $25.75 $111K 41,816
2025-10-15 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −755 $26.17 $20K 41,061
2025-09-17 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −39,435 $26.30 $1.0M 586,812
2025-09-17 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −1,400 $26.87 $38K 585,412

Page 4 of 5 · 92 trades